The effect of adaptive servo ventilation therapy on cardiovascular disease in heart failure patients with cardiac implantable electronic devices.
Not Applicable
Completed
- Conditions
- chronic heart failuree
- Registration Number
- JPRN-UMIN000010076
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with cancer, severe infection and traumatic disease. (2) Other patients deemed unsuitable by the principal investigator or investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Absolute and percent changes in frequencies of arrythmia(atrial or ventricular arrhythmia) that are stored in the cardiac implantable electronic devices.
- Secondary Outcome Measures
Name Time Method To assess the concomitant effects of the adaptive servo ventilation therapy and their mechanisms, we also evaluate the absolute and percent changes in following parameters; *cardiac function assessed by echocardiography, *endothelial function (Endo-PAT2000), *oxidative stress markers (dROM/BAP etc), *sleep disorder breathing (AHI), *exercise capacity (5m gait speed), *metabolic status (lipid/glycemic parameters), *renal function, *symptom/QOL, *impedance assessed by devices, *body weight, *drug component, *Prognosis (death, heart failure, etc)